Ocrelizumab (Ocrevus) is a humanized monoclonal antibody targeting CD20, designed to deplete B cells. It operates primarily through antibody-dependent cellular cytotoxicity (ADCC), effectively inhibiting lesion formation in multiple sclerosis models in mice. This mechanism underscores its potential for application in research focused on autoimmune diseases and immunotherapy.
Ocrelizumab (Ocrevus) is a humanized monoclonal antibody targeting CD20, designed to deplete B cells. It operates primarily through antibody-dependent cellular cytotoxicity (ADCC), effectively inhibiting lesion formation in multiple sclerosis models in mice. This mechanism underscores its potential for application in research focused on autoimmune diseases and immunotherapy.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
